PRECIPIO, INC. Restructuring Charges
PRECIPIO, INC. (PRPO) reported Restructuring Charges of $0 for the 12-month period ending 2013-12-31, per its 10-K filed 2014-03-27.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RestructuringCharges · last filed 2014-03-27
- PRECIPIO, INC. restructuring charges for the quarter ending 2012-12-31 was $0.00, a 100.00% decline year-over-year.
- PRECIPIO, INC. restructuring charges for the quarter ending 2012-09-30 was $0.00, a 100.00% decline year-over-year.
- PRECIPIO, INC. restructuring charges for the quarter ending 2012-06-30 was $0.00, a 100.00% decline year-over-year.
- PRECIPIO, INC. restructuring charges for the quarter ending 2012-03-31 was $0.00, a 100.00% decline year-over-year.
- PRECIPIO, INC. restructuring charges for fiscal 2013 was $0.00.
- PRECIPIO, INC. restructuring charges for fiscal 2012 was $0.00, a 100.00% decline from fiscal 2011.
- PRECIPIO, INC. restructuring charges for fiscal 2011 was $41.00K, a 70.29% decline from fiscal 2010.
- PRECIPIO, INC. restructuring charges for fiscal 2010 was $138.00K.
| Period end | Restructuring Charges 3 month | Restructuring Charges 6 month | Restructuring Charges 9 month | Restructuring Charges 12 month |
|---|---|---|---|---|
| 2013-12-31 | $0.00 10-K · filed 2014-03-27 | |||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-27 | $0.00 derived: sum of 2 quarters · filed 2014-03-27 | $0.00 derived: sum of 3 quarters · filed 2014-03-27 | $0.00 10-K · filed 2014-03-27 |
| 2012-09-30 | $0.00 10-Q · filed 2012-11-08 | $0.00 derived: sum of 2 quarters · filed 2012-11-08 | $0.00 10-Q · filed 2012-11-08 | $1.00K derived: sum of 4 quarters · filed 2014-03-27 |
| 2012-06-30 | $0.00 10-Q · filed 2012-08-02 | $0.00 10-Q · filed 2012-08-02 | $1.00K derived: sum of 3 quarters · filed 2014-03-27 | $6.00K derived: sum of 4 quarters · filed 2014-03-27 |
| 2012-03-31 | $0.00 10-Q · filed 2012-05-09 | $1.00K derived: sum of 2 quarters · filed 2014-03-27 | $6.00K derived: sum of 3 quarters · filed 2014-03-27 | $17.00K derived: sum of 4 quarters · filed 2014-03-27 |
| 2011-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-27 | $6.00K derived: sum of 2 quarters · filed 2014-03-27 | $17.00K derived: sum of 3 quarters · filed 2014-03-27 | $41.00K 10-K · filed 2014-03-27 |
| 2011-09-30 | $5.00K 10-Q · filed 2012-11-08 | $16.00K derived: sum of 2 quarters · filed 2012-11-08 | $40.00K 10-Q · filed 2012-11-08 | $106.00K derived: sum of 4 quarters · filed 2013-03-14 |
| 2011-06-30 | $11.00K 10-Q · filed 2012-08-02 | $35.00K 10-Q · filed 2012-08-02 | $101.00K derived: sum of 3 quarters · filed 2013-03-14 | $173.00K derived: sum of 4 quarters · filed 2013-03-14 |
| 2011-03-31 | $24.00K 10-Q · filed 2012-05-09 | $90.00K derived: sum of 2 quarters · filed 2013-03-14 | $162.00K derived: sum of 3 quarters · filed 2013-03-14 | $162.00K derived: sum of 4 quarters · filed 2013-03-14 |
| 2010-12-31 | $66.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-14 | $138.00K derived: sum of 2 quarters · filed 2013-03-14 | $138.00K derived: sum of 3 quarters · filed 2013-03-14 | $138.00K 10-K · filed 2013-03-14 |
| 2010-09-30 | $72.00K 10-Q · filed 2011-11-10 | $72.00K derived: sum of 2 quarters · filed 2011-11-10 | $72.00K 10-Q · filed 2011-11-10 | |
| 2010-06-30 | $0.00 10-Q · filed 2011-08-12 | $0.00 10-Q · filed 2011-08-12 | ||
| 2009-12-31 | $0.00 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |